PAHC(Phibro Animal Health Corporation) · 财务报表

PAHC(Phibro Animal Health Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-06-30FY 截至 2023-06-30FY 截至 2024-06-30FY 截至 2025-06-30FY 截至 2026-06-30
营业收入$942.26M$977.89M$1.02B$1.30B$1.52B
毛利润$285.40M$298.24M$313.09M$399.94M$512.51M
营业利润$78.99M$71.85M$53.31M$110.47M$194.40M
净利润$49.17M$32.61M$2.42M$48.26M$99.72M
经营现金流$31.65M$13.31M$87.59M$80.12M$68.95M
自由现金流−$5.39M−$38.48M$46.36M$41.83M$9.87M
摊薄每股收益$1.21$0.81$0.06$1.19$2.43

Phibro Animal Health Corporation PAHC